Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Bulgaria Germany Hungary Italy The Netherlands +1
  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Recruiting

    3 1 1 1
    Belgium
  • A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation

    Recruiting

    2 1
    Investigated Diseases:
    Germany The Netherlands
  • Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

    Recruiting

    2 1
    Investigated Drugs:
    Bulgaria Denmark Germany Hungary Italy The Netherlands +1
  • Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Germany The Netherlands Spain
  • Evaluation of a Single Measurement Strategy for Direct Oral Anticoagulants in Frail Older Patients with Atrial Fibrillation or Venous Thromboembolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on Amiodarone Hydrochloride for Treating Atrial Fibrillation in Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation

    Recruiting

    4 1 1 1
    Finland Sweden
  • Study Comparing Two Amiodarone Doses to Maintain Heart Rhythm in Patients with Persistent Atrial Fibrillation After Cardioversion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    Poland